← Back to Search

Psychedelic

Psilocybin Therapy for Chronic Lower Back Pain (POP Trial)

Phase 1 & 2
Recruiting
Led By Joshua Woolley
Research Sponsored by Joshua Woolley, MD/PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 25 to 70 years old
Has tried at least two previous medications/ procedures and physical therapy trials for low back pain
Must not have
Chronic low back pain that is attributed to malignancy, subacute or acute fracture or infection
Low back pain with neurologic signs present
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-week, 1-month, and 3-months after psilocybin session
Awards & highlights
Approved for 5 Other Conditions

Summary

This trial will assess if psilocybin therapy helps people manage chronic low back pain. Participants will get doses of psilocybin, along with other drugs, and counseling.

Who is the study for?
This trial is for adults aged 25-70 with chronic low back pain, who are comfortable in English and can attend sessions at UCSF. They should have tried at least two other treatments without success. It's not for those with pain due to cancer, fractures, infections, or if the pain extends below the knee with neurological signs.
What is being tested?
The study tests psilocybin therapy's effectiveness on chronic low back pain. Participants will receive psilocybin combined with Modafinil, Zolpidem, both drugs or a placebo in various sessions including preparation and follow-ups to discuss their experiences.
What are the potential side effects?
Psilocybin may cause temporary changes in perception, mood swings, dizziness or headaches. Modafinil could lead to insomnia or anxiety while Zolpidem might result in daytime drowsiness or unusual dreams.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 25 and 70 years old.
Select...
I have tried at least two treatments and physical therapy for my low back pain.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My chronic low back pain is due to cancer, a recent fracture, or an infection.
Select...
I have low back pain with signs of nerve issues.
Select...
I have low back pain that spreads below my knee.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-week, 1-month, and 3-months after psilocybin session
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-week, 1-month, and 3-months after psilocybin session for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in average pain intensity
Change in clinical depressive symptom severity
Change in depressive symptom severity
+1 more

Awards & Highlights

Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Psilocybin in combination with Zolpidem and ModafinilExperimental Treatment1 Intervention
Single dose of Psilocybin (1mg-30mg) in combination with zolpidem and modafinil
Group II: Psilocybin in combination with ZolpidemExperimental Treatment1 Intervention
Single dose of Psilocybin (1mg-30mg) in combination with zolpidem
Group III: Psilocybin in combination with PlaceboExperimental Treatment1 Intervention
Single dose of Psilocybin (1mg-30mg) in combination with placebo
Group IV: Psilocybin in combination with ModafinilExperimental Treatment1 Intervention
Single dose of Psilocybin (1mg-30mg) in combination with modafinil

Find a Location

Who is running the clinical trial?

Joshua Woolley, MD/PhDLead Sponsor
1 Previous Clinical Trials
12 Total Patients Enrolled
Joshua WoolleyPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
20 Total Patients Enrolled
~0 spots leftby Dec 2024